完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | 沈培鈞 | en_US |
dc.contributor.author | Shen, Pei-Chun | en_US |
dc.contributor.author | 楊進木 | en_US |
dc.contributor.author | Yang, Jinn-Moon | en_US |
dc.date.accessioned | 2015-11-26T01:02:03Z | - |
dc.date.available | 2015-11-26T01:02:03Z | - |
dc.date.issued | 2015 | en_US |
dc.identifier.uri | http://140.113.39.130/cdrfb3/record/nctu/#GT070257206 | en_US |
dc.identifier.uri | http://hdl.handle.net/11536/127154 | - |
dc.language.iso | zh_TW | en_US |
dc.subject | 舊藥新用 | zh_TW |
dc.subject | 蛋白質激酶抑制劑 | zh_TW |
dc.subject | 抗發炎反應 | zh_TW |
dc.subject | 同源藥理 | zh_TW |
dc.subject | Drug repurposing | en_US |
dc.subject | Protein kinase inhibitor | en_US |
dc.subject | Anti-inflammation | en_US |
dc.subject | Homopharma | en_US |
dc.title | 舊藥新用:首款FDA核准藥物藉由抑制IRAK4及其訊息傳遞途徑達到抗發炎之效用 | zh_TW |
dc.title | Drug repurposing: the first FDA drug inhibits IRAK4 and pathways for anti-inflammation | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | 生物資訊及系統生物研究所 | zh_TW |
顯示於類別: | 畢業論文 |